ConductScience.org, home

Paper25771069

Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial.

Huo Y and 31 others. JAMA, 2015. Cited by 588 papers, by iCite.

Cite this record

ConductScience Library. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. Papers, record 25771069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25771069

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial.
PubMed
Journal
JAMA
PubMed
Year
2015
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
588
iCite
Relative citation ratio, by iCite
21.9
iCite
Revised in PubMed
2026-05-18
PubMed

Authors32

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huo YYong
2Li JJianping
3Qin XXianhui
4Huang YYining
5Wang XXiaobin
6Gottesman RFRebecca F
7Tang GGenfu
8Wang BBinyan
9Chen DDafang
10He MMingli
11Fu JJia
12Cai YYefeng
13Shi XXiuli
14Zhang YYan
15Cui YYimin
16Sun NNingling
17Li XXiaoying
18Cheng XXiaoshu
19Wang JJian'an
20Yang XXinchun

Source PubMed

See all 32 authorsDownload CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
EnalaprilMajor topic
Folic AcidMajor topic
HypertensionMajor topic
StrokeMajor topic
Vitamin B ComplexMajor topic
China
Double-Blind Method
Drug Therapy, Combination
Humans
Kaplan-Meier Estimate
Male
Methylenetetrahydrofolate Reductase (NADPH2)
Middle Aged
Polymorphism, Genetic
Primary Prevention
Risk

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R21 AI079872NIAID NIH HHSUnited StatesR21AI079872PubMed and NIHNIH RePORTER
R21 ES011666NIEHS NIH HHSUnited StatesR21ES011666PubMed and NIHNIH RePORTER
R21 HD066471NICHD NIH HHSUnited StatesR21HD066471PubMed and NIHNIH RePORTER
U01 AI090727NIAID NIH HHSUnited StatesU01AI090727PubMed and NIHNIH RePORTER
R01HD086013NIHNIH RePORTER

Download CSV of grants

Trials7

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00794885China Stroke Primary Prevention TrialDerived from the trialYesClinicalTrials.gov
NCT02817503Feasibility Study of the Intensive Systolic Blood Pressure ControlBackgroundClinicalTrials.gov
NCT03472508H-Type Hypertension Precision Medicine TrialResultsClinicalTrials.gov
NCT04974138China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)ResultsClinicalTrials.gov
NCT04974151China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT GenotypeResultsClinicalTrials.gov
NCT05169021Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVDResultsClinicalTrials.gov
NCT07680595Prospective Management of Plaque Instability With Statins and Extra Folic AcidResultsClinicalTrials.gov

Download CSV of trials

Comments and corrections5

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in25770867Folate supplements for stroke prevention: targeted trial trumps the rest.https://conductscience.org/library/papers/25770867PubMed
Comment in25778787Folic acid significantly reduces risk of first stroke, large Chinese study finds.https://conductscience.org/library/papers/25778787PubMed
Comment in25824518Hypertension. Folic acid reduces stroke risk.https://conductscience.org/library/papers/25824518PubMed
Comment in26187470Folic Acid for Stroke Prevention: Time to Revisit Vitamin Therapy in Patients With Kidney Disease?https://conductscience.org/library/papers/26187470PubMed
Comment in26192588ACP Journal Club. In Chinese adults with hypertension, adding folic acid to enalapril reduced incident stroke.https://conductscience.org/library/papers/26192588PubMed

Download CSV of comments and corrections

Cited by375

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 588 citations.

PMIDTitleJournalYearIn PapersSource
42884618The Proposed Vitamin D-Homocysteine Relationship in Cardiometabolic Health: A Narrative Review of Mechanisms, Evidence, and Research Phenotypes.Nutrients2026https://conductscience.org/library/papers/42884618PubMed
42760941MTHFR C677T TT genotype associated with poor blood pressure control in H-type hypertension without folic acid: a retrospective cohort study.Front Pharmacol2026https://conductscience.org/library/papers/42760941PubMed
42739064Unmetabolized Folic Acid: Biology, Epidemiology, and Clinical Consequences: A Systematic Review.Nutrients2026https://conductscience.org/library/papers/42739064PubMed
42580670Development of a Prognostic Model for MACE in Atherosclerosis Based on MTHFR and Serum Markers.Clin Appl Thromb Hemost2026https://conductscience.org/library/papers/42580670PubMed
42540469Annexin A1 as a diagnostic biomarker for cyclic Cushing disease.iScience2026https://conductscience.org/library/papers/42540469PubMed
42489966Micronutrients and omega-3 PUFAs to promote healthy ageing: informing a physiology-based complementation strategy.Geroscience2026https://conductscience.org/library/papers/42489966PubMed
42470822Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases.Pharmacol Rev2026https://conductscience.org/library/papers/42470822PubMed
42430052Hyperhomocysteinemia, a risk factor for various health conditions: an umbrella review of systematic reviews with meta-analysis.Aging Clin Exp Res2026https://conductscience.org/library/papers/42430052PubMed
42410840Impact of folic acid supplementation on cardiovascular risk among individuals with hemorrhagic stroke: A prospective study.Medicine (Baltimore)2026https://conductscience.org/library/papers/42410840PubMed
42395085Intake of B vitamins and their circulating levels in relation to incident stroke in women and men: Findings from two national prospective cohorts in the United States.Am J Prev Cardiol2026https://conductscience.org/library/papers/42395085PubMed
42346130Astrocytic Redox Homeostasis as a Metabolic Modulator of DNA Damage and Repair in the Ischemic Penumbra.Cells2026https://conductscience.org/library/papers/42346130PubMed
42251786Fenofibrate attenuates hyperhomocysteinemia-potentiated thrombosis by restoring platelet fatty acid β-oxidation.Redox Biol2026https://conductscience.org/library/papers/42251786PubMed
42209710
Lifestyle profiles and long-term blood pressure control are associated with lower risks of stroke and all-cause mortality among treated hypertensive patients: findings from the China Stroke Primary Prevention Trial.
J Hum Hypertens2026https://conductscience.org/library/papers/42209710PubMed
42100908Folate and global health review series, part 3: syntheses on cardiovascular, cerebrovascular, and metabolic diseases.J Glob Health2026https://conductscience.org/library/papers/42100908PubMed
42067935B vitamins and cardiovascular health: mechanisms, clinical evidence, and precision prevention strategies.Nutr Metab (Lond)2026https://conductscience.org/library/papers/42067935PubMed
42057125Inflammaging and the role of micronutrients as immunomodulators: a pathway to healthy aging.Immun Ageing2026https://conductscience.org/library/papers/42057125PubMed
42015255Serine Hydroxymethyltransferase (SHMT) in biology and disease: molecular mechanisms and therapeutic targeting.J Transl Med2026https://conductscience.org/library/papers/42015255PubMed
41917692The Neutrophil Percentage-to-Albumin Ratio: An Emerging Biomarker Associated With Primary Stroke Risk in Hypertensive Patients.J Clin Hypertens (Greenwich)2026https://conductscience.org/library/papers/41917692PubMed
41890215One-carbon metabolism and cardiovascular disease: Molecular mechanisms, genetic influences, and epigenetic regulation.Biochem Biophys Rep2026https://conductscience.org/library/papers/41890215PubMed
41830012Complex Effects of B-Vitamin Combinations on Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials over Three Decades.Nutrients2026https://conductscience.org/library/papers/41830012PubMed

See all 375 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MTHFR4524PubTator's text mininghttps://conductscience.org/library/genes/4524

Source NCBI Gene

Download CSV of genes

Drugs4

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
LEVOMEFOLIC ACIDCHEMBL1231574Results1https://conductscience.org/library/drugs/CHEMBL1231574ChEMBL
AMLODIPINECHEMBL1491Results3https://conductscience.org/library/drugs/CHEMBL1491ChEMBL
FOLIC ACIDCHEMBL1622Results2https://conductscience.org/library/drugs/CHEMBL1622ChEMBL
ENALAPRILCHEMBL578Results2https://conductscience.org/library/drugs/CHEMBL578ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • References
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25771069

GET https://conductscience.org/api/papers/v1/25771069/authors?page=2